GSK Plc's market value is the price at which a share of GSK Plc trades on a public exchange. It measures the collective expectations of GSK plc investors about its performance. GSK Plc is trading at 25.87 as of the 31st of January 2026. This is a 3.52 percent increase since the beginning of the trading day. The stock's lowest day price was 24.99. With this module, you can estimate the performance of a buy and hold strategy of GSK plc and determine expected loss or profit from investing in GSK Plc over a given investment horizon. Check out GSK Plc Correlation, GSK Plc Volatility and GSK Plc Performance module to complement your research on GSK Plc.
Please note, there is a significant difference between GSK Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if GSK Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GSK Plc's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
GSK Plc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GSK Plc's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GSK Plc.
0.00
11/02/2025
No Change 0.00
0.0
In 3 months and 1 day
01/31/2026
0.00
If you would invest 0.00 in GSK Plc on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding GSK plc or generate 0.0% return on investment in GSK Plc over 90 days. GSK Plc is related to or competes with Chugai Pharmaceutical, Sanofi, Chugai Pharmaceutical, CSL, Daiichi Sankyo, MERCK Kommanditgesells, and Merck KGaA. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of ... More
GSK Plc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GSK Plc's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GSK plc upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for GSK Plc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GSK Plc's standard deviation. In reality, there are many statistical measures that can use GSK Plc historical prices to predict the future GSK Plc's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GSK Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GSK Plc appears to be not too volatile, given 3 months investment horizon. GSK plc holds Efficiency (Sharpe) Ratio of 0.0791, which attests that the entity had a 0.0791 % return per unit of risk over the last 3 months. We have found thirty technical indicators for GSK plc, which you can use to evaluate the volatility of the firm. Please utilize GSK Plc's Market Risk Adjusted Performance of (0.51), semi deviation of 2.91, and Risk Adjusted Performance of 0.0769 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, GSK Plc holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of -0.63, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning GSK Plc are expected to decrease at a much lower rate. During the bear market, GSK Plc is likely to outperform the market. Please check GSK Plc's total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether GSK Plc's current trending patterns will revert.
Auto-correlation
0.29
Poor predictability
GSK plc has poor predictability. Overlapping area represents the amount of predictability between GSK Plc time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GSK plc price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current GSK Plc price fluctuation can be explain by its past prices.
GSK Plc financial ratios help investors to determine whether GSK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.